Stock Score Valuation Add to Watchlist SCORE 53 SRPT: Sarepta Therapeutics, Inc. is a Buy AAPL chart by TradingView The current rating for SRPT is 53, which is 6% above its historic median rating of 50. This indicates lower risk than normal. The rating is currently showing a higher than normal reading, suggesting risk levels could be lower than normal. "Do This" Before January 20th Man who predicted 2020 crash now says “Do This” before Jan 20,2021…They called the 2020 crash 45 days early. Nobody expects what they're predicting now...Learn more here!
Login Into Your Account
Sign In with Facebook Sign In with GoogleBy clicking "Sign Up" you indicate that you have read and agree to the Terms of Service and Privacy Policy